MERZEE Drug Patent Profile
When do Merzee patents expire, and what generic alternatives are available?
Merzee is a drug marketed by Wilshire Pharms Inc and is included in one NDA.
The generic ingredient in MERZEE is ethinyl estradiol; norethindrone acetate. There is one drug master file entry for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MERZEE?
- What are the global sales for MERZEE?
- What is Average Wholesale Price for MERZEE?
Summary for MERZEE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for MERZEE |
| DailyMed Link: | MERZEE at DailyMed |
US Patents and Regulatory Information for MERZEE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wilshire Pharms Inc | MERZEE | ethinyl estradiol; norethindrone acetate | CAPSULE;ORAL | 212706-001 | Dec 18, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
